Insider Trading Alert - BXMT, LHCG And BABY Traded By Insiders

Stocks with insider trader activity include BXMT, LHCG and BABY
By TheStreet Wire ,

Yesterday, Nov. 12, 2015, 171 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $57.69 to $70,050,500.00.

Highlighted Stocks Traded by Insiders:

Blackstone Mortgage (BXMT) - FREE Research Report

Ruffing Thomas C, who is Managing Director at Blackstone Mortgage, sold 237 shares at $31.12 on Nov. 12, 2015. Following this transaction, the Managing Director owned 15,152 shares meaning that the stake was reduced by 1.54% with the 237-share transaction.

Rothschild Randall S., who is Secretary & Managing Director at Blackstone Mortgage, sold 355 shares at $31.12 on Nov. 12, 2015. Following this transaction, the Secretary & Managing Director owned 12,089 shares meaning that the stake was reduced by 2.85% with the 355-share transaction.

Marone Anthony F. JR, who is Principal Accounting Officer at Blackstone Mortgage, sold 406 shares at $31.12 on Nov. 12, 2015. Following this transaction, the Principal Accounting Officer owned 11,061 shares meaning that the stake was reduced by 3.54% with the 406-share transaction.

Quinlan Paul D, who is Chief Financial Officer at Blackstone Mortgage, sold 556 shares at $31.12 on Nov. 12, 2015. Following this transaction, the Chief Financial Officer owned 15,072 shares meaning that the stake was reduced by 3.56% with the 556-share transaction.

Armer Douglas N., who is Treasurer, Managing Director at Blackstone Mortgage, sold 1,053 shares at $31.12 on Nov. 12, 2015. Following this transaction, the Treasurer, Managing Director owned 29,805 shares meaning that the stake was reduced by 3.41% with the 1,053-share transaction.

The shares most recently traded at $27.32, down $3.80, or 13.91% since the insider transaction. Historical insider transactions for Blackstone Mortgage go as follows:

  • 4-Week # shares bought: 90,164
  • 4-Week # shares sold: 1,362
  • 12-Week # shares bought: 90,164
  • 12-Week # shares sold: 2,696
  • 24-Week # shares bought: 90,164
  • 24-Week # shares sold: 4,928

The average volume for Blackstone Mortgage has been 688,400 shares per day over the past 30 days. Blackstone Mortgage has a market cap of $2.6 billion and is part of the financial sector and real estate industry. Shares are down 6.21% year-to-date as of the close of trading on Thursday.

Blackstone Mortgage Trust, Inc., a real estate finance company, originates and purchases senior loans collateralized by properties in North America and Europe. It operates through two segments, Loan Origination and CT Legacy Portfolio. The stock currently has a dividend yield of 8.98%. The company has a P/E ratio of 13.6. Currently, there are 6 analysts who rate Blackstone Mortgage a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BXMT - FREE

TheStreet Quant Ratings

rates Blackstone Mortgage as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full

Blackstone Mortgage Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

LHC Group (LHCG) - FREE Research Report

Nixon Ronald T, who is Director at LHC Group, sold 8,505 shares at $48.00 on Nov. 12, 2015. Following this transaction, the Director owned 36,895 shares meaning that the stake was reduced by 18.73% with the 8,505-share transaction.

The shares most recently traded at $45.52, down $2.48, or 5.45% since the insider transaction. Historical insider transactions for LHC Group go as follows:

  • 4-Week # shares sold: 4,732
  • 12-Week # shares sold: 4,732
  • 24-Week # shares sold: 10,456

The average volume for LHC Group has been 163,800 shares per day over the past 30 days. LHC Group has a market cap of $828.3 million and is part of the health care sector and health services industry. Shares are up 44.55% year-to-date as of the close of trading on Thursday.

LHC Group, Inc., together with its subsidiaries, provides post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through three segments: Home-Based Services, Hospice Services, and Facility-Based Services. The company has a P/E ratio of 26.8. Currently, there are 4 analysts who rate LHC Group a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LHCG - FREE

TheStreet Quant Ratings

rates LHC Group as a

buy

. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

LHC Group Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Natus Medical (BABY) - FREE Research Report

Hawkins James B, who is President and CEO at Natus Medical, sold 42,489 shares at $47.62 on Nov. 12, 2015. Following this transaction, the President and CEO owned 434,785 shares meaning that the stake was reduced by 8.9% with the 42,489-share transaction.

The shares most recently traded at $47.18, down $0.44, or 0.92% since the insider transaction. Historical insider transactions for Natus Medical go as follows:

  • 4-Week # shares sold: 4,000
  • 12-Week # shares sold: 4,000
  • 24-Week # shares sold: 4,000

The average volume for Natus Medical has been 266,800 shares per day over the past 30 days. Natus Medical has a market cap of $1.6 billion and is part of the health care sector and health services industry. Shares are up 29.8% year-to-date as of the close of trading on Thursday.

Natus Medical Incorporated designs, manufactures, and markets newborn care and neurology healthcare products and services worldwide. The company has a P/E ratio of 39.1. Currently, there are 3 analysts who rate Natus Medical a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BABY - FREE

TheStreet Quant Ratings

rates Natus Medical as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full

Natus Medical Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Loading ...